• Markets
  • icon
  • Companies
ILA · ASX

Island Pharmaceuticals Ltd (ASX:ILA)

AU$0.065

 0.002 (3.175%)
ASX:Live
17/05/2024 02:51:58 PM
HALO Price Momentum HALO Ords HALO Earnings Momentum GROWTH AUS All-Consensus +1
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

ILA Overview

ILA Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About ILA

Website

N/A

Telephone

N/A

Address

Description

Island Pharmaceuticals Ltd. is a drug research and repurposing company, focused on developing preventative or therapeutic drugs for viral infections. Its Isla101, a drug being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. The company was founded by David Foster on May 25, 2020 and is headquartered in Camberwell, Australia.

ILA Price Chart

Key Stats

Market Cap

AU$7.17M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.05 - 0.13

Trade Value (12mth)

AU$1,478.00

1 week

10.17%

1 month

18.18%

YTD

-26.32%

1 year

-41.67%

All time high

0.6221429705619812

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

-$3m

Free Cash Flow Return

-88.80%

ROIC

-92.70%

Interest Coverage

-323.10

Quick Ratio

7.80

Other Data

Shares on Issue (Fully Dilluted)

88m

HALO Sector

Next Company Report Date

22-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

ILA Announcements

Latest Announcements

Date Announcements

08 May 24

Grant funding to directly support Phase 2a trial

×

Grant funding to directly support Phase 2a trial

06 May 24

Notification of cessation of securities - ILA

×

Notification of cessation of securities - ILA

06 May 24

Change of Director's Interest Notice x5

×

Change of Director's Interest Notice x5

30 April 24

Quarterly Appendix 4C and Activities Report

×

Quarterly Appendix 4C and Activities Report

22 April 24

Investor Presentation - Asia Bio Partnering

×

Investor Presentation - Asia Bio Partnering

17 April 24

Application for quotation of securities - ILA

×

Application for quotation of securities - ILA

16 April 24

Positive data from ISLA-101 Single Ascending Dose study

×

Positive data from ISLA-101 Single Ascending Dose study

04 April 24

Change of Director's Interest Notice x 5

×

Change of Director's Interest Notice x 5

04 April 24

Change in substantial holding

×

Change in substantial holding

04 April 24

Change in substantial holding

×

Change in substantial holding

03 April 24

Change in substantial holding

×

Change in substantial holding

02 April 24

Security Class Reinstatement to Quotation ILAO

×

Security Class Reinstatement to Quotation ILAO

02 April 24

Top 20 Option Holders & Distribution Schedule

×

Top 20 Option Holders & Distribution Schedule

27 March 24

Application for quotation of securities - ILA

×

Application for quotation of securities - ILA

27 March 24

Updated Trading Policy

×

Updated Trading Policy

26 March 24

Application for quotation of securities - ILA

×

Application for quotation of securities - ILA

26 March 24

Security Class Suspension from Quotation ILAO

×

Security Class Suspension from Quotation ILAO

21 March 24

Update - Proposed issue of securities - ILA

×

Update - Proposed issue of securities - ILA

19 March 24

Results of Rights Issue Offer

×

Results of Rights Issue Offer

05 March 24

Letter to ineligible shareholders

×

Letter to ineligible shareholders

05 March 24

Despatch of Rights Issue documentation

×

Despatch of Rights Issue documentation

26 February 24

Appendix 4D & Half-Year Financial Statements

×

Appendix 4D & Half-Year Financial Statements

26 February 24

$1.95million Fully Underwritten Rights Issue

×

$1.95million Fully Underwritten Rights Issue

26 February 24

Prospectus

×

Prospectus

26 February 24

Proposed issue of securities - ILA

×

Proposed issue of securities - ILA

ILA Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.03 -0.03 -0.03 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.03 -0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -22.1 -0.6 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.01 -0.03 -0.03 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.01 -0.02 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -127.9 0.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -4.1 -15.9 -35.1 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.08 0.05 0.02 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.08 0.05 0.02 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -32.8 -61.6 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 81 81 88 Lock Lock Lock
Basic m Lock Lock Lock Lock 81 81 88 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 2 3 3 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -31.3 -3.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -31.3 -3.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -2 -3 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -22.6 -8.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -1 -2 -3 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 7 0 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -1 -2 -3 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -100.1 -44.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 6 5 2 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 7 5 2 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -6 -5 -2 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 0 1 0 Lock Lock Lock
Equity $m Lock Lock Lock Lock 6 4 2 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 6 4 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A -32.5 -58.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -32.0 -53.2 -138.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -33.2 -60.4 -158.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock N/A -52.4 -95.3 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock N/A -48.6 -92.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock N/A -35.0 -88.8 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A -323.1 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.0 1.7 0.7 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -101.0 -110.9 -111.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 28.0 8.4 7.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 28.0 8.4 7.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 97.4 97.7 97.5 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -396.2 -323.3 -1,026.6 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock N/A 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -32.0 -53.2 -138.1 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.0 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -33.2 -60.4 -158.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -33.2 -60.4 -158.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

ILA Shortsell

Frequently Asked Questions

The current share price of Island Pharmaceuticals Ltd (ILA:ASX) is AU$0.065.
The 52-week high share price for Island Pharmaceuticals Ltd (ILA:ASX) is AU$0.13.
The 52-week low share price for Island Pharmaceuticals Ltd (ILA:ASX)? is AU$0.05.
Island Pharmaceuticals Ltd (ILA:ASX) does not pay a dividend.
Island Pharmaceuticals Ltd (ILA:ASX) does not pay a dividend.
Island Pharmaceuticals Ltd (ILA:ASX) has a franking level of 0.0%.
Island Pharmaceuticals Ltd (ILA:ASX) is classified in the Healthcare.
The current P/E ratio for Island Pharmaceuticals Ltd (ILA:ASX) is .